HWM
WST icon

Hemington Wealth Management’s West Pharmaceutical WST Stock Holding History

Hemington Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$93K Buy
357
+30
+9% +$7.29K 0.01% 253
2025
Q2 		$71K Buy
327
+1
+0.3% +$214 0.01% 272
2025
Q1 		$72K Sell
326
-10
-3% -$2.76K 0.01% 258
2024
Q4 		$110K Buy
336
+8
+2% +$2.52K 0.03% 183
2024
Q3 		$101K Buy
+328
New +$100K 0.03% 186

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Hemington Wealth Management's WST Position: Q3 2025 in Review

Hemington Wealth Management increased its West Pharmaceutical (WST) stake by 9.2% in Q3 2025, buying an estimated $7.29K and bringing the position to 357 shares worth $93K. The position accounts for 0.01% of the portfolio, ranked #253.

Hemington Wealth Management first reported a position in WST in Q3 2024 and has held it in 5 quarters since. The position peaked at $110K in Q4 2024. 756 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Hemington Wealth Management held 357 shares of West Pharmaceutical worth $93K as of Q3 2025.
  • Hemington Wealth Management bought 30 West Pharmaceutical shares in Q3 2025, an estimated $7.29K.
  • West Pharmaceutical made up 0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #253 holding.
  • Hemington Wealth Management first reported a position in West Pharmaceutical in Q3 2024 and has held it in 5 quarters since.
  • Hemington Wealth Management's West Pharmaceutical position peaked at $110K in Q4 2024.
  • 756 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.